tiprankstipranks
Trending News
More News >
Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
India Market

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

Compare
0 Followers

Top Page

IN:KRITINUT

Kriti Nutrients Limited

(KRITINUT)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 4o)
Rating:60Neutral
Price Target:
₹94.00
▲(40.28% Upside)
Kriti Nutrients Limited's overall stock score is primarily influenced by its strong financial performance, particularly its robust balance sheet. However, bearish technical indicators and modest valuation metrics suggest caution. The company needs to address profitability and cash flow challenges to improve its stock attractiveness.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage and high equity ratios provides financial stability and reduces risk exposure, supporting long-term growth.
Revenue Growth
Consistent revenue growth indicates effective market penetration and product demand, enhancing the company's competitive position and future prospects.
Efficient Operations
Strong EBITDA margins reflect operational efficiency, enabling the company to maintain profitability and invest in growth initiatives.
Negative Factors
Declining Net Profit Margin
A declining net profit margin suggests rising costs or reduced pricing power, which could pressure profitability and limit reinvestment capacity.
Free Cash Flow Concerns
Decreasing free cash flow growth may hinder the company's ability to fund operations and strategic initiatives, impacting long-term sustainability.
Earnings Decline
A significant decline in earnings per share growth reflects challenges in maintaining profitability, which could affect investor confidence and future growth potential.

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Kriti Nutrients Limited Business Overview & Revenue Model

Company DescriptionKriti Nutrients Limited (KRITINUT) is a leading player in the agricultural and nutritional sectors, specializing in the production and distribution of a wide range of nutrient supplements and fertilizers. The company focuses on enhancing agricultural productivity and improving soil health through innovative products designed for both conventional and organic farming practices. KRITINUT offers a diverse portfolio, including micronutrients, bio-fertilizers, and specialty nutrient formulations that cater to the needs of farmers and agricultural businesses globally.
How the Company Makes MoneyKriti Nutrients Limited generates revenue primarily through the sale of its agricultural nutrient products, including various fertilizers and supplements. The company's revenue model is anchored in direct sales to farmers, agricultural cooperatives, and distribution networks that connect them with end-users. Key revenue streams include bulk sales to large agricultural enterprises, retail sales through partnered agricultural supply stores, and online sales through e-commerce platforms. Additionally, KRITINUT may engage in strategic partnerships with agricultural research organizations and government initiatives aimed at promoting sustainable farming practices, which can lead to increased market penetration and brand visibility. The company may also benefit from contracts with agricultural institutions and NGOs for providing tailored solutions and products, further diversifying its income sources.

Kriti Nutrients Limited Financial Statement Overview

Summary
Kriti Nutrients Limited maintains a strong financial position with stable revenue growth and efficient operations. The balance sheet is robust with low leverage and high equity ratios. However, the decrease in net profit margin and free cash flow growth highlights areas for improvement in cost management and cash flow efficiency.
Income Statement
72
Positive
Kriti Nutrients Limited has shown a stable revenue growth with a 7.47% increase from 2024 to 2025. The gross profit margin for 2025 is 13.99%, which is consistent with industry standards. However, the net profit margin declined to 5.03% from 6.63% the previous year, indicating increased costs or reduced pricing power. EBITDA margin remains strong at 7.60%, suggesting efficient operations despite the reduced EBIT margin of 5.80%.
Balance Sheet
78
Positive
The company's balance sheet is robust, characterized by a low debt-to-equity ratio of 0.01, indicating minimal financial leverage. The equity ratio is high at 89.06%, reflecting strong equity backing. Return on equity is 17.46%, showing effective use of shareholder funds to generate profits. Overall, the balance sheet reflects financial stability with low risk exposure.
Cash Flow
65
Positive
Kriti Nutrients has demonstrated a decline in free cash flow growth, with a significant decrease from 2024 to 2025, posing a concern. The operating cash flow to net income ratio is 0.86, suggesting adequate conversion of net income into cash. However, free cash flow to net income is 0.74, indicating potential pressures on cash flow generation.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.76B7.34B6.83B7.96B7.51B6.90B
Gross Profit953.65M1.03B1.07B780.37M679.84M378.97M
EBITDA489.64M557.89M666.67M356.28M222.83M242.58M
Net Income322.11M369.94M452.87M207.98M123.05M150.57M
Balance Sheet
Total Assets0.002.38B2.09B1.93B1.68B1.24B
Cash, Cash Equivalents and Short-Term Investments137.86M265.85M210.43M190.38M37.16M30.21M
Total Debt0.0030.69M121.45M403.73M375.58M35.38M
Total Liabilities-2.12B259.39M325.25M607.00M554.76M232.38M
Stockholders Equity2.12B2.12B1.76B1.32B1.13B1.01B
Cash Flow
Free Cash Flow0.00273.10M409.62M133.43M-193.72M38.16M
Operating Cash Flow0.00319.58M498.13M198.61M-105.10M90.22M
Investing Cash Flow0.00-288.64M-291.87M-31.35M-199.81M11.95M
Financing Cash Flow0.00-106.49M-304.01M-14.05M311.86M-72.13M

Kriti Nutrients Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price67.01
Price Trends
50DMA
80.31
Negative
100DMA
87.88
Negative
200DMA
95.67
Negative
Market Momentum
MACD
-4.64
Positive
RSI
32.40
Neutral
STOCH
19.47
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 67.01 is below the 20-day moving average (MA) of 72.22, below the 50-day MA of 80.31, and below the 200-day MA of 95.67, indicating a bearish trend. The MACD of -4.64 indicates Positive momentum. The RSI at 32.40 is Neutral, neither overbought nor oversold. The STOCH value of 19.47 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹12.35B26.0423.11%1930.97%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
₹12.83B97.830.06%
60
Neutral
₹3.33B10.540.44%16.35%-32.55%
56
Neutral
₹2.26B8.471.70%-71.32%
54
Neutral
₹4.35B10.39-3.96%
52
Neutral
₹3.35B29.24-29.77%-60.54%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KRITINUT
Kriti Nutrients Limited
67.01
-58.02
-46.40%
IN:IFBAGRO
IFB Agro Industries Ltd.
1,439.70
865.90
150.91%
IN:KOTHARIPRO
Kothari Products Limited.
74.05
-27.15
-26.83%
IN:PASHUPATI
Pashupati Cotspin Ltd.
830.85
328.36
65.35%
IN:SAKHTISUG
Sakthi Sugars Limited
19.17
-11.71
-37.92%
IN:TRF
TRF Limited.
305.00
-114.15
-27.23%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients Announces Financial Results and Dividend
Nov 8, 2025

Kriti Nutrients Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2025. The board of directors also declared an interim dividend of Rs. 3.00 per equity share to commemorate three decades of the Kriti Oil brand. This decision reflects the company’s strong financial performance and its commitment to rewarding shareholders, potentially enhancing its market position and investor confidence.

Kriti Nutrients Declares Interim Dividend and Approves Financial Results
Nov 8, 2025

Kriti Nutrients Limited’s Board of Directors announced an interim dividend of Rs. 3.00 per equity share, marking the celebration of three decades of the Kriti Oil Brand. The Board also approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. This announcement reflects the company’s commitment to rewarding its shareholders and maintaining transparency in its financial disclosures.

Kriti Nutrients Announces Interim Dividend to Celebrate Brand Milestone
Nov 8, 2025

Kriti Nutrients Limited has announced a record date for the payment of an interim dividend, set for November 13, 2025. This dividend, amounting to Rs. 3.00 per equity share, marks a 300% return on the face value of Rs. 1/- each, and is intended to celebrate decades of the Kriti Oil brand. This announcement reflects the company’s strong financial performance and commitment to rewarding its shareholders, potentially enhancing its market position and investor confidence.

Kriti Nutrients Declares 300% Interim Dividend for FY 2025-26
Nov 8, 2025

Kriti Nutrients Limited has announced the approval and payment of an interim dividend of Rs. 3 per share, marking a 300% dividend on its equity shares for the financial year 2025-26. This decision celebrates three decades of the Kriti Oil brand and reflects the company’s strong financial performance, benefiting shareholders and reinforcing its market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025